NERVE GROWTH-FACTOR IN DIFFERENT CRYSTAL FORMS DISPLAYS STRUCTURAL FLEXIBILITY AND REVEALS ZINC-BINDING SITES

被引:90
作者
HOLLAND, DR
COUSENS, LS
MENG, W
MATTHEWS, BW
机构
[1] UNIV OREGON,INST MOLEC BIOL,EUGENE,OR 97403
[2] UNIV OREGON,HOWARD HUGHES MED INST,EUGENE,OR 97403
[3] UNIV OREGON,DEPT PHYS,EUGENE,OR 97403
[4] CHIRON CORP,EMERYVILLE,CA 94608
关键词
DIMER; CRYSTAL PACKING; DISULFIDE KNOT; NEUTROPHINS; RECEPTORS;
D O I
10.1006/jmbi.1994.1380
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Murine β-nerve growth factor (βNGF) is a 118 amino acid residue polypeptide which, as a functional dimer, plays an important role in the survival and development of certain neuronal populations. The structure of the bis-desocta1-8 form of murine βNGF has been determined in two different crystal modifications using X-ray methods. The two crystal forms, with space groups P212121 and C2, were grown from 18 to 20% polyethylene glycol 8000 and 100 mM Pipes (pH 6.1) with zinc acetate concentrations of I mM and 100 mM, respectively. The C2 structure was solved by multiple isomorphous replacement using four heavy-atom derivatives and was refined to a crystallographic residual of 17.9% and 2.5 Å resolution. The crystals contain three βNGF monomers per asymmetric unit. Two monomers form a dimer related by a non-crystallographic 2-fold axis of symmetry. The third monomer also forms a dimer that is very similar, but with a crystallography related monomer as a partner. The electron density clearly defines residues 12 through 115 for all three monomers but the extreme N and C-terminal residues (9 to 11, 116 to 118) are ill defined in some cases. The P212121 structure was solved by molecular replacement using the C2 structure as a search model and was refined to a crystallographic residual of 19.7% at 2.8 Å resolution. This crystal form contains two monomers per asymmetric unit, again arranged as a non-crystallographic 2-fold-related dimer. The N and C termini are also variably defined. The core of each of the five monomers, which forms a cysteine knot motif, is very similar in all structures. Also, the dimer structures are very similar to one another, whether the monomers are related by crystallographic or non-crystallographic symmetry. However, three of the four loop regions that extend from the core of each monomer display substantial variability in conformation, even between monomers of the same dimer. This structural variability in the putative receptor binding regions suggests that structural malleability might be important in allowing the ligands to bind to different receptors with different affinities. The five new models for the βNGF monomer confirm and extend the structure of βNGF previously reported by T. L. Blundell and colleagues. In addition, a zinc-binding site in the ‘waist’ of the molecule near His84 and AsplO5 has been identified. © 1994 Academic Press Limited.
引用
收藏
页码:385 / 400
页数:16
相关论文
共 43 条
[1]   CRYSTAL-STRUCTURE OF THE SOLUBLE HUMAN 55 KD TNF RECEPTOR-HUMAN TNF-BETA COMPLEX - IMPLICATIONS FOR TNF RECEPTOR ACTIVATION [J].
BANNER, DW ;
DARCY, A ;
JANES, W ;
GENTZ, R ;
SCHOENFELD, HJ ;
BROGER, C ;
LOETSCHER, H ;
LESSLAUER, W .
CELL, 1993, 73 (03) :431-445
[2]  
BOTHWELL MA, 1977, J BIOL CHEM, V252, P8532
[3]  
Crowther R. A., 1972, MOL REPLACEMENT METH, P173
[4]   A METHOD OF POSITIONING A KNOWN MOLECULE IN AN UNKNOWN CRYSTAL STRUCTURE [J].
CROWTHER, RA ;
BLOW, DM .
ACTA CRYSTALLOGRAPHICA, 1967, 23 :544-&
[5]   CRYSTAL-STRUCTURE OF TRANSFORMING GROWTH-FACTOR-BETA-2 - AN UNUSUAL FOLD FOR THE SUPERFAMILY [J].
DAOPIN, S ;
PIEZ, KA ;
OGAWA, Y ;
DAVIES, DR .
SCIENCE, 1992, 257 (5068) :369-373
[6]  
DARLING TL, 1984, CELL CULTURE METHODS, V4, P79
[7]   HUMAN GROWTH-HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR - CRYSTAL-STRUCTURE OF THE COMPLEX [J].
DEVOS, AM ;
ULTSCH, M ;
KOSSIAKOFF, AA .
SCIENCE, 1992, 255 (5042) :306-312
[8]   AFFINITY LABELING AND PARTIAL-PURIFICATION OF NERVE GROWTH-FACTOR RECEPTORS FROM RAT PHEOCHROMOCYTOMA AND HUMAN-MELANOMA CELLS [J].
GROB, PM ;
BERLOT, CH ;
BOTHWELL, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (22) :6819-6823
[9]  
HAMLIN R, 1985, METHOD ENZYMOL, V114, P416
[10]  
HEFTI F, 1991, CLIN NEUROPHARMAC S1, V14, P62